Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Guru Sonpavde"'
Autor:
Sylvan C. Baca, Sabina Signoretti, Abdallah Flaifel, Sachet A. Shukla, Pier Vitale Nuzzo, Matthew L. Freedman, Guru Sonpavde, Jacob E. Berchuck, Heng Du, Mark M. Awad, Amin Nassar, Natalie I. Vokes, Yvonne Y. Li, Sarah Abou Alaiwi, John A. Steinharter, Marios Giannakis, Ronan Flippot, Toni K. Choueiri, Wanling Xie, Robert I. Haddad, David J. Kwiatkowski, Taiwen Li, David A. Braun, Eliezer M. Van Allen, Andrew D. Cherniack, X. Shirley Liu, Cigall Kadoch, F. Stephen Hodi, Claire A. Margolis, Ziad Bakouny, Liam F. Spurr, Tarek H. Mouhieddine
Publikováno v:
Cancer Immunol Res
Prior data have variably implicated the inactivation of the mammalian SWItch/Sucrose Non-Fermentable (mSWI/SNF) complex with increased tumor sensitivity to immune checkpoint inhibitors (ICI). Herein, we examined the association between mSWI/SNF varia
Autor:
Dominick Bossé, Joaquim Bellmunt, Guillermo de Velasco, Youjin Je, F. Stephen Hodi, Patrick A. Ott, Toni K. Choueiri, Guru Sonpavde, Raphael Brandao Moreira, Mark M. Awad, Fabio A.B. Schutz
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Immune-related adverse events (irAE) have been described with immune checkpoint inhibitors (ICI), but the incidence and relative risk (RR) of irAEs associated with these drugs remains unclear. We selected five key irAEs from treatments with approved
Autor:
Sumati Gupta, Ewan A. Gibb, Elai Davicioni, Neeraj Agarwal, Bharat Thyagarajan, Guru Sonpavde, Shilpa Gupta, Christopher J. Weight, Badrinath R. Konety
Publikováno v:
Cancer Immunology Research. 7:A008-A008
Background: Cisplatin-based neoadjuvant chemotherapy in muscle-invasive bladder cancer (MIBC) improves survival which correlates with pathologic response (PaR) at radical cystectomy (RC). Immunotherapy with checkpoint inhibitors has improved outcomes